by | Jul 6, 2024 | Publications
Proc Natl Acad Sci U S A. 2024 Jul 9;121(28):e2410959121. doi: 10.1073/pnas.2410959121. Epub 2024 Jul 5. NO ABSTRACT PMID:38968129 | DOI:10.1073/pnas.2410959121
by | Jul 5, 2024 | Publications
Br J Haematol. 2024 Jul 4. doi: 10.1111/bjh.19624. Online ahead of print. ABSTRACT A decade after International Myeloma Working Group (IMWG) biomarkers (SLiM criteria) were introduced, this real-world study examined their impact on diagnosis, therapy and outcomes in...
by | Jul 5, 2024 | Publications
Hemasphere. 2024 Jul 4;8(7):e85. doi: 10.1002/hem3.85. eCollection 2024 Jul. NO ABSTRACT PMID:38966208 | PMC:PMC11223651 | DOI:10.1002/hem3.85
by | Jul 5, 2024 | Publications
Zhonghua Xue Ye Xue Za Zhi. 2024 May 14;45(5):430-435. doi: 10.3760/cma.j.cn121090-20240312-00090. ABSTRACT High-risk multiple myeloma (HRMM) refers to patients with multiple myeloma whose overall survival time is less than 2-3 years under current standardized...
by | Jul 5, 2024 | Publications
Zhonghua Xue Ye Xue Za Zhi. 2024 May 14;45(5):436-444. doi: 10.3760/cma.j.cn121090-20240131-00047. ABSTRACT Objective: To construct a novel chimeric antigen receptor T (CAR-T) cell targeting CD138 and to investigate its cytotoxicity against myeloma cells. Methods: The...
by | Jul 5, 2024 | Publications
Zhonghua Xue Ye Xue Za Zhi. 2024 May 14;45(5):475-480. doi: 10.3760/cma.j.cn121090-20231020-00221. ABSTRACT Objective: To explore the correlation of bone marrow polychonal plasma cell proportion (pPC% ) and clinical features in newly diagnosed multiple myeloma (NDMM)...
